mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for NPR3
Gene summary
Basic gene Info.Gene symbolNPR3
Gene namenatriuretic peptide receptor 3
SynonymsANP-C|ANPR-C|ANPRC|C5orf23|GUCY2B|NPR-C|NPRC
CytomapUCSC genome browser: 5p13.3
Type of geneprotein-coding
RefGenesNM_000908.3,
NM_001204375.1,NM_001204376.1,NM_024563.3,
Descriptionatrial natriuretic peptide clearance receptoratrial natriuretic peptide receptor 3atrial natriuretic peptide receptor type Catrionatriuretic peptide receptor Cguanylate cyclase Cnatriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic pep
Modification date20141207
dbXrefs MIM : 108962
HGNC : HGNC
Ensembl : ENSG00000113389
HPRD : 00167
Vega : OTTHUMG00000150316
ProteinUniProt: P17342
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_NPR3
BioGPS: 4883
PathwayNCI Pathway Interaction Database: NPR3
KEGG: NPR3
REACTOME: NPR3
Pathway Commons: NPR3
ContextiHOP: NPR3
ligand binding site mutation search in PubMed: NPR3
UCL Cancer Institute: NPR3
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for NPR3

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
Y138Y138HSTAD3
N110G109WLUAD1
D237D237YLUAD1
E333F332SLUAD1
R211R211WLUAD1
M337S336FSKCM1
A161A159VSTAD1
Y171Y171HSTAD1
K208L209PUCEC1
Y204Y204CUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for NPR3
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
E333F332S-1.485769
R211R211W-1.4801065
Y171Y171H-1.2384075
K208L209P-1.0530624
Y138Y138H-1.0166234
M337S336F-0.8709796
Y204Y204C-0.72483403
D237D237Y-0.37139464
A161A159V-0.31943553
N110G109W-0.3065982
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for NPR3 from PDB
PDB IDPDB titlePDB structure
1JDNCrystal Structure of Hormone Receptor

Top
Differential gene expression and gene-gene network for NPR3
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of NPR3 and the right PPI network was created from samples without mutations in the LBS of NPR3. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for NPR3
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0033578Prostatic Neoplasms1Biomarker
umls:C0043094Weight Gain1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for NPR3
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|investigationalDB04899NesiritideBiotech

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of NPR3 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of NPR3
Multiple alignments for P17342 in multiple species
LBSAA sequence# speciesSpecies
A141CEYAAAPVARL3Homo sapiens, Rattus norvegicus, Bos taurus
A161SAGALAAGFQH3Homo sapiens, Rattus norvegicus, Bos taurus
A162AGALAAGFQHK3Homo sapiens, Rattus norvegicus, Bos taurus
D206ALVYSDDKLER1Homo sapiens
D206ALLYSDDKLER1Rattus norvegicus
D206VLVYSDDKLER1Bos taurus
D237SAYNFDETKDL2Rattus norvegicus, Bos taurus
D237SIYSFDETKDL1Homo sapiens
E137LGPVCEYAAAP3Homo sapiens, Rattus norvegicus, Bos taurus
E170QHKDTEYSHLT2Rattus norvegicus, Bos taurus
E170QHKDSEYSHLT1Homo sapiens
E218CYFTLEGVHEV2Homo sapiens, Rattus norvegicus
E218CFFTLEGVHEV1Bos taurus
E222LEGVHEVFQEE3Homo sapiens, Rattus norvegicus, Bos taurus
E333VKPEFEKFSME2Homo sapiens, Bos taurus
E333AKPEFEKFSME1Rattus norvegicus
F164ALAAGFQHKDT2Rattus norvegicus, Bos taurus
F164ALAAGFQHKDS1Homo sapiens
F215ERNCYFTLEGV2Homo sapiens, Rattus norvegicus
F215ERNCFFTLEGV1Bos taurus
F236TSAYNFDETKD2Rattus norvegicus, Bos taurus
F236TSIYSFDETKD1Homo sapiens
G163GALAAGFQHKD3Homo sapiens, Rattus norvegicus, Bos taurus
H166AAGFQHKDTEY2Rattus norvegicus, Bos taurus
H166AAGFQHKDSEY1Homo sapiens
H221TLEGVHEVFQE3Homo sapiens, Rattus norvegicus, Bos taurus
I233GLHTSAYNFDE2Rattus norvegicus, Bos taurus
I233GLHTSIYSFDE1Homo sapiens
K208VYSDDKLERNC2Homo sapiens, Bos taurus
K208LYSDDKLERNC1Rattus norvegicus
K240SFDETKDLDLE1Homo sapiens
K240NFDETKDLDLD1Rattus norvegicus
K240NFDETKDLDLE1Bos taurus
K438GDYFGKEGRFE2Homo sapiens, Bos taurus
K438GDYFGKEGRFK1Rattus norvegicus
M337FEKFSMEVKSS3Homo sapiens, Rattus norvegicus, Bos taurus
N110DSDCGNRALFS3Homo sapiens, Rattus norvegicus, Bos taurus
P142EYAAAPVARLA3Homo sapiens, Rattus norvegicus, Bos taurus
Q225VHEVFQEEGLH3Homo sapiens, Rattus norvegicus, Bos taurus
R145AAPVARLASHW3Homo sapiens, Rattus norvegicus, Bos taurus
R211DDKLERNCYFT2Homo sapiens, Rattus norvegicus
R211DDKLERNCFFT1Bos taurus
S235HTSAYNFDETK2Rattus norvegicus, Bos taurus
S235HTSIYSFDETK1Homo sapiens
T396QTWNRTFEGIA3Homo sapiens, Rattus norvegicus, Bos taurus
Y138GPVCEYAAAPV3Homo sapiens, Rattus norvegicus, Bos taurus
Y171HKDTEYSHLTR2Rattus norvegicus, Bos taurus
Y171HKDSEYSHLTR1Homo sapiens
Y204RAALVYSDDKL1Homo sapiens
Y204RAALLYSDDKL1Rattus norvegicus
Y204RAVLVYSDDKL1Bos taurus
Y214LERNCYFTLEG2Homo sapiens, Rattus norvegicus
Y214LERNCFFTLEG1Bos taurus
Y234LHTSAYNFDET2Rattus norvegicus, Bos taurus
Y234LHTSIYSFDET1Homo sapiens


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas